Litigation Details for Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited (D. Del. 2015)
✉ Email this page to a colleague
Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-01-13 |
| Court | District Court, D. Delaware | Date Terminated | 2018-04-09 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,713,446; 6,958,319 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-01-13 | 1 | 18. United States Patent No. 6,713,446 (“the ’446 patent”), entitled “Formulation of Boronic…Injection prior to the expiration of U.S. Patent Nos. 6,713,446 and 6,958,319. … INFRINGEMENT OF U.S. PATENT NO. 6,713,446 27. Millennium incorporates… 1. This is an action for patent infringement under the patent laws of the United States, Title… 19. United States Patent No. 6,958,319 (“the ’319 patent”), entitled “Formulation of Boronic | External link to document | |
| 2015-01-13 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2. (…2015 9 April 2018 1:15-cv-00040 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
